Core Insights - The pharmaceutical commercial sector experienced a decline of 0.52% on November 6, with Renmin Tongtai leading the drop [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Stock Performance - The top-performing stock was HeFu China (603122), which closed at 14.34, up 9.97% with a trading volume of 1.2541 million shares and a transaction value of 1.757 billion [1] - Other notable gainers included Yinghe Shiyao (002788) at 9.33, up 5.19%, and Yingche Dong (002462) at 14.68, up 1.45% [1] - Conversely, Renmin Tongtai (600829) saw a significant drop of 9.98%, closing at 65.6 with a trading volume of 521,700 shares and a transaction value of 500 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 467 million from institutional investors, while retail investors saw a net inflow of 408 million [2] - The overall capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Individual Stock Capital Flow - Notable net inflows from retail investors were observed in stocks like Yifeng Pharmacy (603939) with a retail net inflow of 412.67 million, while institutional investors had a net inflow of 287.47 million in Nanjing Pharmaceutical (600713) [3] - Conversely, stocks like Luyuan Pharmaceutical (002788) and Jia Shitang (002462) experienced net outflows from both institutional and retail investors [3]

11月5日，建发致新盘中下跌2.00%，截至09:52，报34.71元/股，成交1.29亿元，换手率7.33%，总市值 146.23亿元。 资金流向方面，主力资金净流入161.18万元，特大单买入0.00元，占比0.00%，卖出243.24万元，占比 1.88%；大单买入2943.74万元，占比22.78%，卖出2539.32万元，占比19.65%。 建发致新今年以来股价跌5.06%，近5个交易日涨0.84%，近20日涨19.73%。 截至9月30日，建发致新股东户数3.80万，较上期增加151.60%；人均流通股1327股，较上期减少 60.25%。2025年1月-9月，建发致新实现营业收入148.61亿元，同比增长10.18%；归母净利润2.30亿元， 同比增长45.01%。 责任编辑：小浪快报 今年以来建发致新已经11次登上龙虎榜，最近一次登上龙虎榜为11月4日，当日龙虎榜净买入-1033.40 万元；买入总计6681.03万元 ，占总成交额比10.34%；卖出总计7714.43万元 ，占总成交额比11.93%。 资料显示，上海建发致新医疗科技集团股份有限公司位于上海市杨浦区杨树浦路288号9层，成立日 ...

建发致新今日上涨5.20%，全天换手率36.94%，成交额6.46亿元，振幅9.82%。龙虎榜数据显示，机构净 卖出1295.62万元，营业部席位合计净买入262.22万元。 深交所公开信息显示，当日该股因日换手率达36.94%上榜，机构专用席位净卖出1295.62万元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 机构专用 | 2180.45 | 1950.93 | | 买二 | 机构专用 | 1424.52 | 1732.44 | | 买三 | 机构专用 | 1144.46 | 1506.27 | | 买四 | 招商证券股份有限公司深圳益田路免税商务大厦证券营 业部 | 696.71 | 259.44 | | 买五 | 光大证券股份有限公司象山丹河东路证券营业部 | 646.44 | 39.28 | | 卖一 | 机构专用 | 2180.45 | 1950.93 | | 卖二 | 机构专用 | 1424.52 | 1732.44 | | 卖三 | 机构专用 | 1144.46 | ...

Market Overview - The pharmaceutical commercial sector declined by 0.5% on November 4, with Baiyang Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] Stock Performance - Notable gainers included: - HeFu China (603122) with a closing price of 11.85, up 10.03% [1] - Renmin Tongtai (600829) at 9.71, up 8.01% [1] - Jianfa Zhixin (301584) at 35.42, up 5.20% [1] - Baiyang Pharmaceutical (301015) saw a significant decline, closing at 25.62, down 6.09% [2] - Other notable decliners included: - Yifeng Pharmacy (603939) at 23.76, down 3.22% [2] - Saili Medical (603716) at 24.78, down 3.17% [2] Capital Flow - The pharmaceutical commercial sector experienced a net inflow of 32.34 million yuan from institutional investors, while retail investors saw a net outflow of 41.10 million yuan [2] - The capital flow for key stocks showed: - Renmin Tongtai had a net inflow of 63.04 million yuan from institutional investors [3] - Yifeng Pharmacy experienced a net outflow of 32.44 million yuan from retail investors [3]

11月3日，建发致新涨3.98%，成交额4.76亿元。两融数据显示，当日建发致新获融资买入额3103.98万 元，融资偿还2824.12万元，融资净买入279.86万元。截至11月3日，建发致新融资融券余额合计9757.93 万元。 融资方面，建发致新当日融资买入3103.98万元。当前融资余额9757.93万元，占流通市值的5.75%。 融券方面，建发致新11月3日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元。 资料显示，上海建发致新医疗科技集团股份有限公司位于上海市杨浦区杨树浦路288号9层，成立日期 2010年8月30日，上市日期2025年9月25日，公司主营业务涉及从事医疗器械直销及分销业务,并为终端 医院提供医用耗材集约化运营(SPD)服务。主营业务收入构成为：血管介入55.61%，外科器械21.46%， 检验试剂(IVD)13.05%，医疗设备6.24%，其他医疗器械2.79%，SPD及其他服务0.63%，其他(补 充)0.23%。 截至9月30日，建发致新股东户数3.80万，较上期增加151.60%；人均流通股1327股， ...

Core Insights - The pharmaceutical commercial sector experienced a rise of 0.69% on November 3, with HeFu China leading the gains [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - HeFu China (603122) closed at 10.77, with a significant increase of 10.01% and a trading volume of 252,300 shares, amounting to a transaction value of 271 million [1] - Jianfa Zhixin (301584) saw a rise of 3.98%, closing at 33.67 with a trading volume of 143,300 shares [1] - Renmin Tongtai (600829) increased by 3.93%, closing at 8.99 with a trading volume of 337,500 shares [1] - Other notable performers include Jia Shitang (002462) with a 2.43% increase and Sai Li Medical (603716) with a 2.36% increase [1] Capital Flow Analysis - The pharmaceutical commercial sector experienced a net outflow of 78.21 million from institutional investors, while retail investors saw a net inflow of 94.46 million [2] - The top stocks by net inflow from retail investors include Renmin Tongtai (600829) with 17.00 million and Baiyang Pharmaceutical (301015) with 16.33 million [3] - Conversely, institutional investors showed a significant net inflow in Guoyao Yizhi (000028) with 15.04 million, indicating strong institutional interest [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别风险提示： 上海建发致新医疗科技集团股份有限公司（以下简称"公司"）及控股子公司提供担保总额超过公司最近 一期经审计净资产100%，对资产负债率超过70%的控股子公司预计担保金额超过公司最近一期经审计 净资产50%，提请投资者充分关注担保风险。 本次预计的对外担保事项，系合并报表范围内公司及子公司之间的担保，上述担保事项已经公司第三届 董事会第八次会议、第三届监事会第七次会议和2024年年度股东大会审议通过。 一、对外担保情况概述 根据公司经营发展战略、资金预算和资金安全等需要，自公司2024年年度股东大会之日起，至2025年年 度股东大会召开之日止，公司及控股子公司拟向各银行等金融机构申请综合授信总额不超过人民币150 亿元（其中40亿元尚待公司2025年第二次临时股东大会审议通过后生效）。 鉴于上述授信总额中部分授信额度的融资主体为公司控股子公司，为保障子公司顺利申请授信额度，自 公司2024年年度股东大会之日起，至2025年年度股东大会召开之日止，公司预 ...

（原标题：建发致新10月31日龙虎榜数据） 近半年该股累计上榜龙虎榜10次，上榜次日股价平均跌1.04%，上榜后5日平均跌0.08%。 资金流向方面，今日该股主力资金净流出4588.43万元，其中，特大单净流出2953.78万元，大单资金净流出1634.65万元。近5日主力资金净流出 9466.70万元。（数据宝） 建发致新10月31日交易公开信息 | 买/卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 机构专用 | 1608.28 | 1303.37 | | 买二 | 机构专用 | 1488.90 | 2234.93 | | 买三 | 机构专用 | 1120.07 | 932.57 | | 买四 | 机构专用 | 777.42 | 997.50 | | 买五 | 东方财富证券股份有限公司拉萨东环路第二证券营业部 | 426.89 | 526.90 | | 卖一 | 机构专用 | 1488.90 | 2234.93 | | 卖二 | 机构专用 | 1608.28 | 1303.37 | | 卖三 | 机构专用 | 777 ...

Market Performance - The ChiNext Index fell by 2.31%, closing at 3187.53 points, with a total trading volume of 595.35 billion yuan, a decrease of 49.949 billion yuan from the previous trading day [1] - Among the tradable ChiNext stocks, 1,078 stocks closed higher, with 14 stocks rising over 10%, including Fushikonggu, Haixia Innovation, and Rongxin Culture, which hit the daily limit [1] - The average turnover rate for the ChiNext today was 4.09%, with 21 stocks exceeding a turnover rate of 20% [1] High Turnover Stocks - The highest turnover stock was Haike Xinyuan, which closed up 17.69% with a turnover rate of 55.34% and a trading volume of 1.682 billion yuan [1] - Other notable high turnover stocks included Haixia Innovation, which hit the daily limit with a turnover rate of 42.56%, and Chuling Information with a turnover rate of 39.32% [1] Sector Analysis - The sectors with the most stocks exceeding a 20% turnover rate included power equipment and computers, each with five stocks listed [3] - Among the high turnover stocks, 21 reported Q3 earnings, with significant net profit growth seen in Xianfeng New Materials (1852.52%), Beifang Changlong (208.52%), and Chuling Information (119.64%) [4] Institutional Activity - In terms of institutional trading, five stocks appeared on the Dragon and Tiger list, with notable net purchases in Kangzhi Pharmaceutical (73.79 million yuan) and Haixia Innovation (60.80 million yuan) [3] - The stocks with the highest net inflows included BlueFocus (695 million yuan), Haixia Innovation (157 million yuan), and Haike Xinyuan (155 million yuan) [2][3] Summary of Key Stocks - Key stocks with significant daily performance included: - Haike Xinyuan: Latest closing price 36.25 yuan, daily increase 17.69%, turnover rate 55.34%, net inflow 155.18 million yuan [4] - Haixia Innovation: Latest closing price 10.25 yuan, daily increase 20.02%, turnover rate 42.56%, net inflow 157.37 million yuan [4] - Chuling Information: Latest closing price 26.77 yuan, daily increase 0.64%, turnover rate 39.32%, net outflow 113.47 million yuan [4]

Core Points - The Shanghai Composite Index rose by 0.11% this week, with 46 stocks having a turnover rate exceeding 100% [1] - The average increase for stocks with a turnover rate over 100% was 9.31%, with 32 stocks rising and 14 falling [2] Turnover Rate Analysis - A total of 46 stocks had a turnover rate above 100%, while 270 stocks had a turnover rate between 50% and 100%, and 2836 stocks had a turnover rate between 10% and 50% [1] - The basic chemical industry had the highest number of stocks with a turnover rate over 100%, totaling 8 stocks, followed by the computer and machinery equipment sectors, each with 7 stocks [1] Individual Stock Performance - Chaoying Electronics had the highest turnover rate at 279.46%, with a price drop of 13.43% and a net outflow of 267.18 million yuan [1] - Taikai Ying followed with a turnover rate of 240.73%, a price drop of 8.41%, and a net outflow of 7.12 million yuan [1][2] - Jianfa Zhixin ranked third with a turnover rate of 221.57%, a price drop of 9.20%, and a net outflow of 95 million yuan [2] Notable Stock Movements - The stocks with the highest gains included Haixia Innovation, with a rise of 60.66%, and Xianfeng New Materials, with a rise of 43.49% [2] - The stocks with the largest declines included Shilong Industry, with a drop of 21.91%, and Shandong Molong, with a drop of 14.01% [2] Financial Performance - Among the stocks with a turnover rate over 100%, 46 have released their Q3 reports, with Daoshengtianhe showing the highest net profit growth of 56.89% year-on-year [2]